Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside Analogues
Clinical trial NCT02792088 · COMPLETED
Trial details
- NCT number
- NCT02792088
- Sponsor
- IlDong Pharmaceutical Co Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2020-02-01
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.